Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BT-007
i
Other names:
BT-007, BT-007 CD7 CAR-T cells, BT007, BT 007
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Bioceltech
Drug class:
CD7-targeted CAR-T immunotherapy
Related drugs:
‹
4SCAR7U (0)
Autologous CAR-T cells (0)
BEAM-201 (0)
CD7 CAR-T (0)
CD7 CAR-T Cell (0)
CD7-UCAR-γδT cells (0)
CTD-402 (0)
CTD401 (0)
GC027 (0)
GC502 (0)
PA3-17 (0)
S101 (0)
ThisCART7 (0)
WU CART 007 (0)
anti-CD7 CAR-T cell therapy (0)
autologous CD7-CAR T cells (0)
4SCAR7U (0)
Autologous CAR-T cells (0)
BEAM-201 (0)
CD7 CAR-T (0)
CD7 CAR-T Cell (0)
CD7-UCAR-γδT cells (0)
CTD-402 (0)
CTD401 (0)
GC027 (0)
GC502 (0)
PA3-17 (0)
S101 (0)
ThisCART7 (0)
WU CART 007 (0)
anti-CD7 CAR-T cell therapy (0)
autologous CD7-CAR T cells (0)
›
Associations
News
Trials
Filter by
Latest
3years
Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL (clinicaltrials.gov)
P1, N=15, Recruiting, Bioceltech Therapeutics, Ltd.
3 years ago
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
BT-007
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.